Vicent Mwesigye
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Vicent Mwesigye has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Benson Musinguzi
Department of Medical Laboratory Sciences, Faculty of Health Sciences, Muni University, Arua, Uganda
7 shared publications - Muzafaru Twinomujuni
Department of Microbiology, Faculty of Medicine, Mbarara University of Science and Technology, P.O Box 1410, Mbarara, Uganda
6 shared publications - Henry Zamarano
Uganda Protestant Medical Bureau, Zion Estate, Bulaga, Kampala
5 shared publications - Ivan Muhwezi
Mbarara University of Science and Technology
5 shared publications - Catherine Khakasa
Mbarara University of Science and Technology
4 shared publications - Deborah Natumanya
Mbarara University of Science and Technology
4 shared publications
Latest Publications
- Open Access
- 21 July 2026
- Published by Elsevier in SSRN Electronic Journal
Distribution and Antibiotic Susceptibility Profile of Bacterial Uropathogens Isolated from Pregnant Women Attending Antenatal Care at Itojo Hospital, Southwestern Uganda
Background: Urinary tract infections (UTIs) are among the most common bacterial infections during pregnancy and remain a significant cause of maternal and neonatal morbidity, particularly in low-resource settings. The increasing antimicrobial resistance among uropathogens has complicated the empirical management of UTIs, highlighting the need for local surveillance of bacterial distribution and antimicrobial susceptibility patterns.Objective: To determine the prevalence, distribution, and antimicrobial susceptibility profiles of bacterial uropathogens isolated from urine specimens of pregnant women attending antenatal Care at Itojo Hospital, Southwestern UgandaMethods: A cross-sectional study was conducted among 299 pregnant women attending the antenatal clinic. Midstream urine specimens were collected and cultured on Cystine Lactose Electrolyte Deficient (CLED) agar. Bacterial isolates were identified using conventional biochemical methods. Antimicrobial susceptibility testing was performed using the Kirby–Bauer disc diffusion method according to the Clinical and Laboratory Standards Institute (CLSI) 2024 guidelines.Results: Of the 299 urine specimens analysed, 89 (29.8%) yielded significant bacterial growth. Nine bacterial species were identified, with Escherichia coli (31.5%) and Klebsiella species (28.1%) being the predominant isolates. Other organisms included Citrobacter freundii, Enterobacter species, Proteus species, Morganella species, and Citrobacter divergens. Antimicrobial susceptibility testing revealed high resistance to cefotaxime and ceftriaxone, whereas imipenem demonstrated the highest antimicrobial activity against the isolated uropathogens.Conclusion: Bacterial uropathogens are common among pregnant women attending antenatal care in Ntungamo District. The high levels of resistance to commonly prescribed antibiotics underscore the need for routine urine culture and antimicrobial susceptibility testing, strengthened antimicrobial stewardship programmes, and evidence-based empirical treatment guidelines to improve the management of UTIs during pregnancy.
- 21 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessDistribution and Antibiotic Susceptibility Profile of Bacterial Uropathogens Isolated from Pregnant Women Attending Antenatal Care at Itojo Hospital, Southwestern Uganda
Background: Urinary tract infections (UTIs) are among the most common bacterial infections during pregnancy and remain a significant cause of maternal and neonatal morbidity, particularly in low-resource settings. The increasing antimicrobial resistance among uropathogens has complicated the empirical management of UTIs, highlighting the need for local surveillance of bacterial distribution and antimicrobial susceptibility patterns.Objective: To determine the prevalence, distribution, and antimicrobial susceptibility profiles of bacterial uropathogens isolated from urine specimens of pregnant women attending antenatal Care at Itojo Hospital, Southwestern UgandaMethods: A cross-sectional study was conducted among 299 pregnant women attending the antenatal clinic. Midstream urine specimens were collected and cultured on Cystine Lactose Electrolyte Deficient (CLED) agar. Bacterial isolates were identified using conventional biochemical methods. Antimicrobial susceptibility testing was performed using the Kirby–Bauer disc diffusion method according to the Clinical and Laboratory Standards Institute (CLSI) 2024 guidelines.Results: Of the 299 urine specimens analysed, 89 (29.8%) yielded significant bacterial growth. Nine bacterial species were identified, with Escherichia coli (31.5%) and Klebsiella species (28.1%) being the predominant isolates. Other organisms included Citrobacter freundii, Enterobacter species, Proteus species, Morganella species, and Citrobacter divergens. Antimicrobial susceptibility testing revealed high resistance to cefotaxime and ceftriaxone, whereas imipenem demonstrated the highest antimicrobial activity against the isolated uropathogens.Conclusion: Bacterial uropathogens are common among pregnant women attending antenatal care in Ntungamo District. The high levels of resistance to commonly prescribed antibiotics underscore the need for routine urine culture and antimicrobial susceptibility testing, strengthened antimicrobial stewardship programmes, and evidence-based empirical treatment guidelines to improve the management of UTIs during pregnancy.
- Open Access
- 10 July 2026
- Published by Microbiology Society
- p. 001281.v1
ANTIMICROBIAL RESISTANCE IN ESCHERICHIA COLI ISOLATED FROM DIARRHOEAL PATIENTS IN NAKIVALE REFUGEE SETTLEMENT, SOUTHWESTERN UGANDA
Background Antimicrobial resistance (AMR) is a critical global health crisis, particularly in resource-limited refugee settlements where high population density and inadequate sanitation facilitate the spread of resistant pathogens. This study aimed to determine the prevalence, antimicrobial resistance patterns, and extended-spectrum beta-lactamase (ESBL) genotypes of Escherichia coli among patients with diarrhea in the Nakivale Refugee Settlement, Southwestern Uganda. Methods A cross-sectional study was conducted between January and May 2024 at Nakivale Health Centre III, involving 197 patients presenting with diarrheal symptoms. E. coli isolates were identified using culture, biochemical tests, and MALDI-TOF MS. Pathogenic strains (serogroup O157) were identified via latex agglutination. Antibiotic susceptibility was determined using the Kirby-Bauer disk diffusion method, and ESBL-encoding genes (bla-TEM, bla-CTX-M, and bla-SHV) were detected using polymerase chain reaction. Results E. coli was recovered from 28.9% (57/197) of participants, with the highest recovery rate in children under 13 years (43.6%; p=0.013) and those using open surface water (44.0%; p<0.001). Of the isolates, 72% (41/57) were presumptive pathogenic serogroup O157. These isolates exhibited high resistance to trimethoprim (92.68%), tetracycline (90.24%), and ampicillin (82.93%). Susceptibility remained high for ceftazidime (92.68%). Genotypic analysis of 33 selected isolates revealed a high prevalence of ESBL genes: bla-TEM (96.96%), bla-CTX-M (87.87%), and bla-SHV (45.45%), with 39.39% of isolates concurrently carrying all three genes. Conclusion There is a high burden of multidrug-resistant and ESBL-producing E. coli in the Nakivale Refugee Settlement, driven by the dominance of bla-TEM and bla-CTX-M genes. The strong association between surface water use and infection underscores the urgent need for improved sanitation infrastructure and enhanced antimicrobial stewardship to preserve the efficacy of remaining treatments in displaced populations.
- 10 July 2026
- Published by Microbiology Society
- p. 001281.v1
Open AccessANTIMICROBIAL RESISTANCE IN ESCHERICHIA COLI ISOLATED FROM DIARRHOEAL PATIENTS IN NAKIVALE REFUGEE SETTLEMENT, SOUTHWESTERN UGANDA
Background Antimicrobial resistance (AMR) is a critical global health crisis, particularly in resource-limited refugee settlements where high population density and inadequate sanitation facilitate the spread of resistant pathogens. This study aimed to determine the prevalence, antimicrobial resistance patterns, and extended-spectrum beta-lactamase (ESBL) genotypes of Escherichia coli among patients with diarrhea in the Nakivale Refugee Settlement, Southwestern Uganda. Methods A cross-sectional study was conducted between January and May 2024 at Nakivale Health Centre III, involving 197 patients presenting with diarrheal symptoms. E. coli isolates were identified using culture, biochemical tests, and MALDI-TOF MS. Pathogenic strains (serogroup O157) were identified via latex agglutination. Antibiotic susceptibility was determined using the Kirby-Bauer disk diffusion method, and ESBL-encoding genes (bla-TEM, bla-CTX-M, and bla-SHV) were detected using polymerase chain reaction. Results E. coli was recovered from 28.9% (57/197) of participants, with the highest recovery rate in children under 13 years (43.6%; p=0.013) and those using open surface water (44.0%; p<0.001). Of the isolates, 72% (41/57) were presumptive pathogenic serogroup O157. These isolates exhibited high resistance to trimethoprim (92.68%), tetracycline (90.24%), and ampicillin (82.93%). Susceptibility remained high for ceftazidime (92.68%). Genotypic analysis of 33 selected isolates revealed a high prevalence of ESBL genes: bla-TEM (96.96%), bla-CTX-M (87.87%), and bla-SHV (45.45%), with 39.39% of isolates concurrently carrying all three genes. Conclusion There is a high burden of multidrug-resistant and ESBL-producing E. coli in the Nakivale Refugee Settlement, driven by the dominance of bla-TEM and bla-CTX-M genes. The strong association between surface water use and infection underscores the urgent need for improved sanitation infrastructure and enhanced antimicrobial stewardship to preserve the efficacy of remaining treatments in displaced populations.
- Open Access
- 1 June 2026
- Published by Microbiology Society in Access Microbiology
- Vol. 8 (6)
Burden of extended-spectrum beta-lactamase-producing Enterobacteriaceae among cancer patients in Africa: a systematic review and meta-analysis
Background. Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-P E ) exacerbate infections in cancer patients in settings where antimicrobial resistance threatens health outcomes. This study estimated the prevalence of ESBL-P E among cancer patients in Africa from 1 January 2010 to 31 December 2024. Methods. We searched PubMed, Embase, Web of Science, CINAHL and Global Health for observational studies reporting ESBL-P E prevalence in cancer patients. Studies published in English from 1 January 2010 to 31 December 2024 were included. Two reviewers independently screened studies, extracted data using standardized forms and assessed the quality of articles using the Newcastle–Ottawa Scale. Pooled prevalence was calculated using a random-effects model in RStudio v4.4.2, with heterogeneity assessed with the I ² statistic and publication bias assessed with funnel plots and Egger’s test. Results. Twelve studies from 9 African countries, involving a total of 1,252 cancer patients and 643 identified events, were included. The pooled prevalence of ESBL-P E was 49.4% (95% CI: 36.0–62.9%, I ²=88.3%, P Escherichia coli and Klebsiella pneumoniae predominated. There was no evidence of publication bias based on funnel plot symmetry, Egger’s test ( t =−0.35, P =0.73) and trim-and-fill analysis (no studies imputed; adjusted estimate unchanged). Heterogeneity was substantial ( I ²=88.3%) with a wide 95% prediction interval (22.7–76.5%). Leave-one-out sensitivity analysis confirmed estimate stability (~49%) with persistently high heterogeneity ( I ² range: 81.4–89.4%). Conclusions. The high ESBL-P E prevalence in African cancer patients signals a critical public health issue, necessitating enhanced surveillance, antimicrobial stewardship and intentional infection control measures.
- 1 June 2026
- Published by Microbiology Society in Access Microbiology
- Vol. 8 (6)
Open AccessBurden of extended-spectrum beta-lactamase-producing Enterobacteriaceae among cancer patients in Africa: a systematic review and meta-analysis
Background. Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-P E ) exacerbate infections in cancer patients in settings where antimicrobial resistance threatens health outcomes. This study estimated the prevalence of ESBL-P E among cancer patients in Africa from 1 January 2010 to 31 December 2024. Methods. We searched PubMed, Embase, Web of Science, CINAHL and Global Health for observational studies reporting ESBL-P E prevalence in cancer patients. Studies published in English from 1 January 2010 to 31 December 2024 were included. Two reviewers independently screened studies, extracted data using standardized forms and assessed the quality of articles using the Newcastle–Ottawa Scale. Pooled prevalence was calculated using a random-effects model in RStudio v4.4.2, with heterogeneity assessed with the I ² statistic and publication bias assessed with funnel plots and Egger’s test. Results. Twelve studies from 9 African countries, involving a total of 1,252 cancer patients and 643 identified events, were included. The pooled prevalence of ESBL-P E was 49.4% (95% CI: 36.0–62.9%, I ²=88.3%, P Escherichia coli and Klebsiella pneumoniae predominated. There was no evidence of publication bias based on funnel plot symmetry, Egger’s test ( t =−0.35, P =0.73) and trim-and-fill analysis (no studies imputed; adjusted estimate unchanged). Heterogeneity was substantial ( I ²=88.3%) with a wide 95% prediction interval (22.7–76.5%). Leave-one-out sensitivity analysis confirmed estimate stability (~49%) with persistently high heterogeneity ( I ² range: 81.4–89.4%). Conclusions. The high ESBL-P E prevalence in African cancer patients signals a critical public health issue, necessitating enhanced surveillance, antimicrobial stewardship and intentional infection control measures.
- Open Access
- 23 February 2026
- Published by Microbiology Society
- p. 001120.v3
Burden of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae among Cancer Patients in Africa: A Systematic Review and Meta-Analysis
Background : Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) exacerbate infections in cancer patients, in settings where antimicrobial resistance threatens health outcomes. This study estimated the prevalence of ESBL-PE among cancer patients in Africa from 2010 to 2024. Methods: We searched PubMed, Embase, Web of Science, CINAHL, and Global Health for observational studies reporting ESBL-PE prevalence in cancer patients. Studies published in English from 2010 to 2024 were included. Two reviewers independently screened studies, extracted data using standardized forms, and assessed quality using the Newcastle-Ottawa Scale. Pooled prevalence was calculated using a random-effects model in RStudio v4.4.2, with heterogeneity assessed by I² statistics and publication bias by funnel plots and Egger’s test. Results: Twelve studies from nine African countries, involving 565 patients (305 events) and 687 samples (338 events), were included. The pooled prevalence was 49.9% (95% CI: 23.1%-76.9%, I² = 91.8%, p < 0.001) at the patient level and 48.1% (95% CI: 31.7%-65.0%, I² = 84.0%, p < 0.001) at the sample level. Escherichia coli and Klebsiella pneumoniae predominated, with high resistance to cephalosporins (median: 89.5%-90%) and fluoroquinolones but preserved carbapenem efficacy. Publication bias was evident, and heterogeneity persisted after sensitivity analysis. Conclusions: The high ESBL-PE prevalence in African cancer patients signals a critical public health issue, necessitating enhanced surveillance, antimicrobial stewardship, and intentional infection control measures.
- 23 February 2026
- Published by Microbiology Society
- p. 001120.v3
Open AccessBurden of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae among Cancer Patients in Africa: A Systematic Review and Meta-Analysis
Background : Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) exacerbate infections in cancer patients, in settings where antimicrobial resistance threatens health outcomes. This study estimated the prevalence of ESBL-PE among cancer patients in Africa from 2010 to 2024. Methods: We searched PubMed, Embase, Web of Science, CINAHL, and Global Health for observational studies reporting ESBL-PE prevalence in cancer patients. Studies published in English from 2010 to 2024 were included. Two reviewers independently screened studies, extracted data using standardized forms, and assessed quality using the Newcastle-Ottawa Scale. Pooled prevalence was calculated using a random-effects model in RStudio v4.4.2, with heterogeneity assessed by I² statistics and publication bias by funnel plots and Egger’s test. Results: Twelve studies from nine African countries, involving 565 patients (305 events) and 687 samples (338 events), were included. The pooled prevalence was 49.9% (95% CI: 23.1%-76.9%, I² = 91.8%, p < 0.001) at the patient level and 48.1% (95% CI: 31.7%-65.0%, I² = 84.0%, p < 0.001) at the sample level. Escherichia coli and Klebsiella pneumoniae predominated, with high resistance to cephalosporins (median: 89.5%-90%) and fluoroquinolones but preserved carbapenem efficacy. Publication bias was evident, and heterogeneity persisted after sensitivity analysis. Conclusions: The high ESBL-PE prevalence in African cancer patients signals a critical public health issue, necessitating enhanced surveillance, antimicrobial stewardship, and intentional infection control measures.
- Open Access
- 25 December 2025
- Published by Springer Nature in Cureus
- Vol. 17 (12)
A Student-Led Mentorship Intervention to Enhance Podoconiosis Management Among Healthcare Workers and Village Health Teams in Western Uganda
Podoconiosis is a neglected tropical, nonfilarial lymphedema resulting from prolonged barefoot exposure to irritant volcanic soils. Uganda is among the affected countries, with Kamwenge District documented as endemic. Persistent gaps in knowledge, prevention practices, and access to care contribute to a sustained disease burden. A multidisciplinary team from Mbarara University of Science and Technology conducted a three-day community-based situation analysis and mentorship program in Kamwenge District from October 3 to October 7, 2022. The team included undergraduate and postgraduate trainees in medical laboratory sciences, medicine, nursing, public health, and dermatology under faculty supervision. Following approval from district authorities, 50 community participants were engaged: 30 podoconiosis patients, 12 Village Health Team (VHT) members, five local council leaders, and seven patient caretakers. Activities included free clinical consultations, structured health education, psychosocial counseling, and hands-on demonstrations of limb hygiene, bandaging, appropriate footwear use, and the application of topical antibacterial or antifungal creams. Substantial knowledge gaps related to podoconiosis causation, prevention, and long-term management were identified among both patients and VHTs. Patients described significant stigma, chronic pain, and functional disability, which were also directly observed during mentorship interactions. Practical demonstrations of limb hygiene and bandaging techniques were positively received, and VHTs expressed strong willingness to integrate these practices into routine community follow-up. However, resource limitations, particularly inadequate footwear and medical supplies, emerged as major barriers to sustained self-care. Podoconiosis remains preventable through proper foot hygiene, sustained health education, use of protective footwear, and community empowerment. However, significant knowledge gaps and misconceptions persist in endemic areas of Kamwenge District. The use of multidisciplinary, community-engaged mentorship models can enhance capacity for early detection, self-care, and stigma reduction. Larger district-wide studies are warranted to better characterize the epidemiology and guide sustainable interventions.
- 25 December 2025
- Published by Springer Nature in Cureus
- Vol. 17 (12)
Open AccessA Student-Led Mentorship Intervention to Enhance Podoconiosis Management Among Healthcare Workers and Village Health Teams in Western Uganda
Podoconiosis is a neglected tropical, nonfilarial lymphedema resulting from prolonged barefoot exposure to irritant volcanic soils. Uganda is among the affected countries, with Kamwenge District documented as endemic. Persistent gaps in knowledge, prevention practices, and access to care contribute to a sustained disease burden. A multidisciplinary team from Mbarara University of Science and Technology conducted a three-day community-based situation analysis and mentorship program in Kamwenge District from October 3 to October 7, 2022. The team included undergraduate and postgraduate trainees in medical laboratory sciences, medicine, nursing, public health, and dermatology under faculty supervision. Following approval from district authorities, 50 community participants were engaged: 30 podoconiosis patients, 12 Village Health Team (VHT) members, five local council leaders, and seven patient caretakers. Activities included free clinical consultations, structured health education, psychosocial counseling, and hands-on demonstrations of limb hygiene, bandaging, appropriate footwear use, and the application of topical antibacterial or antifungal creams. Substantial knowledge gaps related to podoconiosis causation, prevention, and long-term management were identified among both patients and VHTs. Patients described significant stigma, chronic pain, and functional disability, which were also directly observed during mentorship interactions. Practical demonstrations of limb hygiene and bandaging techniques were positively received, and VHTs expressed strong willingness to integrate these practices into routine community follow-up. However, resource limitations, particularly inadequate footwear and medical supplies, emerged as major barriers to sustained self-care. Podoconiosis remains preventable through proper foot hygiene, sustained health education, use of protective footwear, and community empowerment. However, significant knowledge gaps and misconceptions persist in endemic areas of Kamwenge District. The use of multidisciplinary, community-engaged mentorship models can enhance capacity for early detection, self-care, and stigma reduction. Larger district-wide studies are warranted to better characterize the epidemiology and guide sustainable interventions.
- Open Access
- 10 November 2025
- Published by Microbiology Society
- p. 001120.v2
Burden of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae among Cancer Patients in Africa: A Systematic Review and Meta-Analysis
Background : Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) exacerbate infections in cancer patients, in settings where antimicrobial resistance threatens health outcomes. This study estimated the prevalence of ESBL-PE among cancer patients in Africa from 2010 to 2024. Methods: We searched PubMed, Embase, Web of Science, CINAHL, and Global Health for observational studies reporting ESBL-PE prevalence in cancer patients. Studies published in English from 2010 to 2024 were included. Two reviewers independently screened studies, extracted data using standardized forms, and assessed quality using the Newcastle-Ottawa Scale. Pooled prevalence was calculated using a random-effects model in RStudio v4.4.2, with heterogeneity assessed by I² statistics and publication bias by funnel plots and Egger’s test. Results: Twelve studies from nine African countries, involving 565 patients (305 events) and 687 samples (338 events), were included. The pooled prevalence was 49.9% (95% CI: 23.1%-76.9%, I² = 91.8%, p < 0.001) at the patient level and 48.1% (95% CI: 31.7%-65.0%, I² = 84.0%, p < 0.001) at the sample level. Escherichia coli and Klebsiella pneumoniae predominated, with high resistance to cephalosporins (median: 89.5%-90%) and fluoroquinolones but preserved carbapenem efficacy. Publication bias was evident, and heterogeneity persisted after sensitivity analysis. Conclusions: The high ESBL-PE prevalence in African cancer patients signals a critical public health issue, necessitating enhanced surveillance, antimicrobial stewardship, and intentional infection control measures.
- 10 November 2025
- Published by Microbiology Society
- p. 001120.v2
Open AccessBurden of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae among Cancer Patients in Africa: A Systematic Review and Meta-Analysis
Background : Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) exacerbate infections in cancer patients, in settings where antimicrobial resistance threatens health outcomes. This study estimated the prevalence of ESBL-PE among cancer patients in Africa from 2010 to 2024. Methods: We searched PubMed, Embase, Web of Science, CINAHL, and Global Health for observational studies reporting ESBL-PE prevalence in cancer patients. Studies published in English from 2010 to 2024 were included. Two reviewers independently screened studies, extracted data using standardized forms, and assessed quality using the Newcastle-Ottawa Scale. Pooled prevalence was calculated using a random-effects model in RStudio v4.4.2, with heterogeneity assessed by I² statistics and publication bias by funnel plots and Egger’s test. Results: Twelve studies from nine African countries, involving 565 patients (305 events) and 687 samples (338 events), were included. The pooled prevalence was 49.9% (95% CI: 23.1%-76.9%, I² = 91.8%, p < 0.001) at the patient level and 48.1% (95% CI: 31.7%-65.0%, I² = 84.0%, p < 0.001) at the sample level. Escherichia coli and Klebsiella pneumoniae predominated, with high resistance to cephalosporins (median: 89.5%-90%) and fluoroquinolones but preserved carbapenem efficacy. Publication bias was evident, and heterogeneity persisted after sensitivity analysis. Conclusions: The high ESBL-PE prevalence in African cancer patients signals a critical public health issue, necessitating enhanced surveillance, antimicrobial stewardship, and intentional infection control measures.
- Open Access
- 27 October 2025
- Published by Springer Nature in Discover Public Health
- Vol. 22 (1) , 1-19
A qualitative study of knowledge, experiences, and healthcare needs of people living with lymphedema in Kamwenge District, rural Uganda
- 27 October 2025
- Published by Springer Nature in Discover Public Health
- Vol. 22 (1) , 1-19
Open AccessA qualitative study of knowledge, experiences, and healthcare needs of people living with lymphedema in Kamwenge District, rural Uganda
- Open Access
- 30 September 2025
- Published by Microbiology Society
- p. 001120.v1
Burden of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae among Cancer Patients in Africa: A Systematic Review and Meta-Analysis
Background : Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) exacerbate infections in cancer patients, in settings where antimicrobial resistance threatens health outcomes. This study estimated the prevalence of ESBL-PE among cancer patients in Africa from 2010 to 2024. Methods: We searched PubMed, Embase, Web of Science, CINAHL, and Global Health for observational studies reporting ESBL-PE prevalence in cancer patients. Studies published in English from 2010 to 2024 were included. Two reviewers independently screened studies, extracted data using standardized forms, and assessed quality using the Newcastle-Ottawa Scale. Pooled prevalence was calculated using a random-effects model in RStudio v4.4.2, with heterogeneity assessed by I² statistics and publication bias by funnel plots and Egger’s test. Results: Twelve studies from nine African countries, involving 565 patients (305 events) and 687 samples (338 events), were included. The pooled prevalence was 49.9% (95% CI: 23.1%-76.9%, I² = 91.8%, p < 0.001) at the patient level and 48.1% (95% CI: 31.7%-65.0%, I² = 84.0%, p < 0.001) at the sample level. Escherichia coli and Klebsiella pneumoniae predominated, with high resistance to cephalosporins (median: 89.5%-90%) and fluoroquinolones but preserved carbapenem efficacy. Publication bias was evident, and heterogeneity persisted after sensitivity analysis. Conclusions: The high ESBL-PE prevalence in African cancer patients signals a critical public health issue, necessitating enhanced surveillance, antimicrobial stewardship, and intentional infection control measures.
- 30 September 2025
- Published by Microbiology Society
- p. 001120.v1
Open AccessBurden of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae among Cancer Patients in Africa: A Systematic Review and Meta-Analysis
Background : Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) exacerbate infections in cancer patients, in settings where antimicrobial resistance threatens health outcomes. This study estimated the prevalence of ESBL-PE among cancer patients in Africa from 2010 to 2024. Methods: We searched PubMed, Embase, Web of Science, CINAHL, and Global Health for observational studies reporting ESBL-PE prevalence in cancer patients. Studies published in English from 2010 to 2024 were included. Two reviewers independently screened studies, extracted data using standardized forms, and assessed quality using the Newcastle-Ottawa Scale. Pooled prevalence was calculated using a random-effects model in RStudio v4.4.2, with heterogeneity assessed by I² statistics and publication bias by funnel plots and Egger’s test. Results: Twelve studies from nine African countries, involving 565 patients (305 events) and 687 samples (338 events), were included. The pooled prevalence was 49.9% (95% CI: 23.1%-76.9%, I² = 91.8%, p < 0.001) at the patient level and 48.1% (95% CI: 31.7%-65.0%, I² = 84.0%, p < 0.001) at the sample level. Escherichia coli and Klebsiella pneumoniae predominated, with high resistance to cephalosporins (median: 89.5%-90%) and fluoroquinolones but preserved carbapenem efficacy. Publication bias was evident, and heterogeneity persisted after sensitivity analysis. Conclusions: The high ESBL-PE prevalence in African cancer patients signals a critical public health issue, necessitating enhanced surveillance, antimicrobial stewardship, and intentional infection control measures.
- Open Access
- 25 July 2025
- Published by Microbiology Society
- p. 001089.v1
Molecular detection of Helicobacter pylori resistance to clarithromycin and fluoroquinolones at Mbarara City Health Centre IV, Southwestern Uganda
Introduction: Helicobacter pylori infection is classified as a human carcinogen that is linked to gastric cancer; the third most common cause of cancer death worldwide. Unfortunately, there is an emerging antimicrobial resistance to commonly used antibiotics in the treatment of H. pylori thus knowing the local prevalence rate of resistance using a molecular test is important to describe evidence-based interventions. Objective(s): To determine the prevalence of resistance of H. pylori to clarithromycin and fluoroquinolones using a molecular test at Mbarara City Health Centre IV, Southwestern Uganda. Method s: We conducted a descriptive cross-sectional study from January 2020 to April 2021where informed consents were obtained from patients who presented with gastrointestinal symptoms. An interview-guided questionnaire was used to collect both demographic and clinical data. Each participant was provided with a sterile stool container and given instructions to collect four scoopfuls of stools. The stool specimen was placed in a cool box and transported to the laboratory within 30 minutes of sample collection for H. pylori antigen analysis and those that were positive for H. pylori were stored in a fridge at a temperature of -20ᵒc for a week, then transported to MBN clinical laboratories for DNA Extraction from stool using the QIAamp DNA Stool Mini Kit (Qiagen, Hilden Germany) to identify the presence of H. pylori and point mutations in the genes responsible for resistance to fluoroquinolone and clarithromycin through multiplex amplification, and reverse hybridization. Associations were determined using Chi square with Fisher’s exact test and statistical significance was set at P < 0.05. Stata (version 18) was used for statistical analysis. Results: The prevalence of H. pylori among participants who presented with Gastrointestinal Symptoms (GIS) was 27%. Sanitation, smoking, source of drinking water, and bloody stool were found to be associated with H. pylori infection. The proportion of H. pylori resistant to clarithromycin (CLA) was 40% and that to fluoroquinolones (FLQ) was 70%. All H. pylori resistant samples to CLA showed a mutation in the 23srRNA gene and for all that were resistant to FLQ, a mutation was detected in the gyrase A gene. Conclusion: There was a high prevalence of H. pylori infection among participants who presented with GIS and these were associated with poor sanitation, smoking, source of drinking water, and bloody stool. H. pylori was highly resistant to FLQ followed by CLA hence limiting the treatment options. This calls for precautions while using these drugs in treatment of H. pylori infection Key words: Helicobacter pylori, resistance to clarithromycin and fluoroquinolones
- 25 July 2025
- Published by Microbiology Society
- p. 001089.v1
Open AccessMolecular detection of Helicobacter pylori resistance to clarithromycin and fluoroquinolones at Mbarara City Health Centre IV, Southwestern Uganda
Introduction: Helicobacter pylori infection is classified as a human carcinogen that is linked to gastric cancer; the third most common cause of cancer death worldwide. Unfortunately, there is an emerging antimicrobial resistance to commonly used antibiotics in the treatment of H. pylori thus knowing the local prevalence rate of resistance using a molecular test is important to describe evidence-based interventions. Objective(s): To determine the prevalence of resistance of H. pylori to clarithromycin and fluoroquinolones using a molecular test at Mbarara City Health Centre IV, Southwestern Uganda. Method s: We conducted a descriptive cross-sectional study from January 2020 to April 2021where informed consents were obtained from patients who presented with gastrointestinal symptoms. An interview-guided questionnaire was used to collect both demographic and clinical data. Each participant was provided with a sterile stool container and given instructions to collect four scoopfuls of stools. The stool specimen was placed in a cool box and transported to the laboratory within 30 minutes of sample collection for H. pylori antigen analysis and those that were positive for H. pylori were stored in a fridge at a temperature of -20ᵒc for a week, then transported to MBN clinical laboratories for DNA Extraction from stool using the QIAamp DNA Stool Mini Kit (Qiagen, Hilden Germany) to identify the presence of H. pylori and point mutations in the genes responsible for resistance to fluoroquinolone and clarithromycin through multiplex amplification, and reverse hybridization. Associations were determined using Chi square with Fisher’s exact test and statistical significance was set at P < 0.05. Stata (version 18) was used for statistical analysis. Results: The prevalence of H. pylori among participants who presented with Gastrointestinal Symptoms (GIS) was 27%. Sanitation, smoking, source of drinking water, and bloody stool were found to be associated with H. pylori infection. The proportion of H. pylori resistant to clarithromycin (CLA) was 40% and that to fluoroquinolones (FLQ) was 70%. All H. pylori resistant samples to CLA showed a mutation in the 23srRNA gene and for all that were resistant to FLQ, a mutation was detected in the gyrase A gene. Conclusion: There was a high prevalence of H. pylori infection among participants who presented with GIS and these were associated with poor sanitation, smoking, source of drinking water, and bloody stool. H. pylori was highly resistant to FLQ followed by CLA hence limiting the treatment options. This calls for precautions while using these drugs in treatment of H. pylori infection Key words: Helicobacter pylori, resistance to clarithromycin and fluoroquinolones
- Open Access
- 17 May 2024
- Published by Springer Nature in BMC Research Notes
- Vol. 17 (1) , 1-6
Sero-antigen prevalence of lymphatic filariasis and risk factors of podoconiosis in Busiriba sub-county, Kamwenge district, Southwestern Uganda, August–September 2018
Objective: Given the neglected nature of filariasis, especially in Uganda where data are scarce, this cross-sectional study aimed to determine the sero-antigen prevalence of lymphatic filariasis and risk factors associated with non-lymphatic filariasis (podoconiosis) in Busiriba Sub-county, Kamwenge District, Uganda, during August–September 2018, to inform targeted elimination efforts. Results: We enrolled 101 participants, among whom 35 (34.7%) had podoconiosis. The sero-antigen prevalence of lymphatic filariasis was 1.0%. Older age and walking barefoot were associated with increased podoconiosis risk. Specifically, individuals aged 25–49 years with had 7.38 times higher odds of podoconiosis (adjusted odds ratio [aOR] = 7.38, 95% CI: 1.36–40.13) compared to those under 25 years, while those aged ≥ 50 years had even higher odds (aOR = 8.49, 95%CI: 1.44–50.15). Additionally, individuals who reported walking barefoot had 14 times higher odds of podoconiosis (aOR = 14.08; 95% CI: 2.49–79.50).
- 17 May 2024
- Published by Springer Nature in BMC Research Notes
- Vol. 17 (1) , 1-6
Open AccessSero-antigen prevalence of lymphatic filariasis and risk factors of podoconiosis in Busiriba sub-county, Kamwenge district, Southwestern Uganda, August–September 2018
Objective: Given the neglected nature of filariasis, especially in Uganda where data are scarce, this cross-sectional study aimed to determine the sero-antigen prevalence of lymphatic filariasis and risk factors associated with non-lymphatic filariasis (podoconiosis) in Busiriba Sub-county, Kamwenge District, Uganda, during August–September 2018, to inform targeted elimination efforts. Results: We enrolled 101 participants, among whom 35 (34.7%) had podoconiosis. The sero-antigen prevalence of lymphatic filariasis was 1.0%. Older age and walking barefoot were associated with increased podoconiosis risk. Specifically, individuals aged 25–49 years with had 7.38 times higher odds of podoconiosis (adjusted odds ratio [aOR] = 7.38, 95% CI: 1.36–40.13) compared to those under 25 years, while those aged ≥ 50 years had even higher odds (aOR = 8.49, 95%CI: 1.44–50.15). Additionally, individuals who reported walking barefoot had 14 times higher odds of podoconiosis (aOR = 14.08; 95% CI: 2.49–79.50).